JTE-852, a novel spleen tyrosine kinase inhibitor, blocks immunoglobulin G-mediated cellular responses and autoimmune reactions in vivo.
about
JTE-852, a novel spleen tyrosine kinase inhibitor, blocks immunoglobulin G-mediated cellular responses and autoimmune reactions in vivo.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
JTE-852, a novel spleen tyrosi ...... autoimmune reactions in vivo.
@en
JTE-852, a novel spleen tyrosi ...... autoimmune reactions in vivo.
@nl
type
label
JTE-852, a novel spleen tyrosi ...... autoimmune reactions in vivo.
@en
JTE-852, a novel spleen tyrosi ...... autoimmune reactions in vivo.
@nl
prefLabel
JTE-852, a novel spleen tyrosi ...... autoimmune reactions in vivo.
@en
JTE-852, a novel spleen tyrosi ...... autoimmune reactions in vivo.
@nl
P2093
P1433
P1476
JTE-852, a novel spleen tyrosi ...... d autoimmune reactions in vivo
@en
P2093
Akira Matsuo
Hatsue Kobayashi
Hidenori Iwasaki
Mutsuyoshi Matsushita
Takahiro Hata
Toshinobu Kato
P304
P356
10.1016/J.LFS.2017.10.029
P407
P50
P577
2017-10-19T00:00:00Z